Skip to main content
. 2020 Aug 1;1156:122297. doi: 10.1016/j.jchromb.2020.122297

Table 3.

Extraction recovery and matrix effect of 6-O-demethylmenisporphine and IS in rat plasma, liver, urine, bile and feces (n = 6).

Sample matrix Analytes QC concentration (ng/mL) Recovery (%) RSD (%) Matrix effect (%) RSD (%)
Plasma 6-O-demethylmenisporphine 15 88.4 ± 7.4 8.4 110.9 ± 3.6 3.2
150 85.5 ± 6.2 7.3 102.4 ± 5.5 5.4
1600 93.2 ± 6.1 6.5 109.3 ± 2.5 2.3
IS 40 80.1 ± 4.0 5.0 90.2 ± 3.8 4.2
Liver 6-O-demethylmenisporphine 6 91.5 ± 7.9 8.6 100.9 ± 12.7 12.6
80 88.2 ± 7.2 8.2 101.2 ± 6.7 6.6
800 92.4 ± 8.5 9.2 105.3 ± 6.7 6.4
IS 40 88.2 ± 7.9 9.0 106.2 ± 12.1 11.4
Urine 6-O-demethylmenisporphine 6 91.3 ± 12.0 13.1 105.5 ± 8.4 7.9
80 94.2 ± 5.2 5.5 98.3 ± 5.9 6.0
800 90.1 ± 6.8 7.5 95.7 ± 7.0 7.3
IS 40 90.9 ± 5.4 5.9 86.1 ± 6.3 7.3
Bile 6-O-demethylmenisporphine 6 97.6 ± 13.3 13.6 89.0 ± 12.6 14.1
80 85.9 ± 9.7 11.3 86.7 ± 11.3 13.0
800 89.9 ± 7.9 8.8 88.4 ± 9.0 10.2
IS 40 81.6 ± 11.7 14.4 85.9 ± 6.9 8.0
Feces 6-O-demethylmenisporphine 6 101.3 ± 9.7 9.5 90.3 ± 10.5 11.7
80 94.3 ± 8.9 9.4 93.1 ± 11.2 12.0
800 84.5 ± 3.8 4.5 87.8 ± 10.0 11.4
IS 40 80.2 ± 8.9 11.1 87.1 ± 11.2 12.9